Steven E Kahn
Overview
Explore the profile of Steven E Kahn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
315
Citations
18254
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sauter K, Webb G, Bader L, Kreklywich C, Takahashi D, Zaro C, et al.
bioRxiv
. 2025 Mar;
PMID: 40027795
Long-term adverse consequences of SARS-CoV-2 infection, termed "long COVID" or post-acute sequelae of COVID (PASC), are a major component of overall COVID-19 disease burden. Prior obesity and metabolic disease increase...
2.
Wander P, Lowy E, Korpak A, Beste L, Kahn S, Boyko E
PLoS One
. 2025 Feb;
20(2):e0317348.
PMID: 39970150
Objective: To examine the impact of SARS-CoV-2 on long-term glycemia. Research Design And Methods: We conducted a retrospective inception cohort study using Veterans Health Administration data (March 1, 2020-May 31,...
3.
Akter R, Hogan M, Esser N, Barrow B, Castillo J, Boyko E, et al.
Endocrinology
. 2025 Feb;
166(3).
PMID: 39928527
Hypercholesterolemia is often observed in individuals with type 2 diabetes. Cholesterol accumulation in subcellular compartments within islet β-cells can result in insulin secretory dysfunction, which is a key pathological feature...
4.
Palmer R, Neiberg R, Beavers K, Kahn S, Houston D, Wagenknecht L, et al.
Obesity (Silver Spring)
. 2025 Feb;
33(3):612-620.
PMID: 39904719
Objective: The objective of this study was to elucidate associations between adiposity reduction and changes in HbA1c and insulin use among adults with type 2 diabetes and overweight or obesity....
5.
6.
7.
Verma S, Emerson S, Plutzky J, Kahn S, Stensen S, Weeke P, et al.
J Am Coll Cardiol
. 2024 Nov;
85(5):541-545.
PMID: 39566870
No abstract available.
8.
Liao C, Fujimoto W, Kahn S, Leonetti D, Boyko E
Obes Res Clin Pract
. 2024 Sep;
18(4):263-268.
PMID: 39277538
Aims: Visceral fat predicts the development of metabolic syndrome (MetS), but it is not known whether the visceral to subcutaneous fat area ratio (VSR) measured using imaging predicts MetS risk...
9.
Esser N, Hogan M, Templin A, Akter R, Fountaine B, Castillo J, et al.
Diabetologia
. 2024 Sep;
67(9):1897-1911.
PMID: 39245780
Aims/hypothesis: Apart from its fibrinolytic activity, the tissue plasminogen activator (tPA)/plasmin system has been reported to cleave the peptide amyloid beta, attenuating brain amyloid deposition in Alzheimer's disease. As aggregation...
10.
Kosiborod M, Deanfield J, Pratley R, Borlaug B, Butler J, Davies M, et al.
Lancet
. 2024 Sep;
404(10456):949-961.
PMID: 39222642
Background: Heart failure with mildly reduced or preserved ejection fraction (hereafter referred to as HFpEF) is the most common type of heart failure and is associated with a high risk...